Showing 18,081 - 18,100 results of 60,573 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((mean decrease) OR (a decrease)) ))', query time: 0.73s Refine Results
  1. 18081

    S4 Fig - by Xinyue Yang (629144)

    Published 2024
    “…On day 8, the rats were transferred to a simulated climate cabin, At 0, 50, 100, and 150 min, the core temperature (Tc) was measured respectively. …”
  2. 18082

    S3 Fig - by Xinyue Yang (629144)

    Published 2024
    “…On day 8, the rats were transferred to a simulated climate cabin, At 0, 50, 100, and 150 min, the core temperature (Tc) was measured respectively. …”
  3. 18083

    S1 File - by Xinyue Yang (629144)

    Published 2024
    “…On day 8, the rats were transferred to a simulated climate cabin, At 0, 50, 100, and 150 min, the core temperature (Tc) was measured respectively. …”
  4. 18084
  5. 18085
  6. 18086

    DataSheet1_Psychotropic Medication Use Before and During COVID-19: A Population-Wide Study.docx by Christine Leong (6429392)

    Published 2022
    “…</p><p>Results: There were 1,394,885 individuals in the first quarter of 2020, with a mean (SD) age of 38.9 (23.4) years, 50.3% were female, and 36.1% had a psychiatric diagnosis in the previous 5 years. …”
  7. 18087
  8. 18088
  9. 18089
  10. 18090
  11. 18091
  12. 18092

    Data_Sheet_1_Immunomodulatory effects of new phytotherapy on human macrophages and TLR4- and TLR7/8-mediated viral-like inflammation in mice.pdf by Olesia Schapovalova (13277163)

    Published 2022
    “…</p>Conclusions<p>Herbal IP-therapy decreases inflammation and, partly, “sickness behavior,” suggesting its potency to combat SARS-CoV-2 infection first of all via its preventive effects.…”
  13. 18093

    Data_Sheet_1_Immunomodulatory effects of new phytotherapy on human macrophages and TLR4- and TLR7/8-mediated viral-like inflammation in mice.pdf by Olesia Schapovalova (13277163)

    Published 2022
    “…</p>Conclusions<p>Herbal IP-therapy decreases inflammation and, partly, “sickness behavior,” suggesting its potency to combat SARS-CoV-2 infection first of all via its preventive effects.…”
  14. 18094
  15. 18095

    DataSheet_1_A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in health... by Richard T. Kenney (15289313)

    Published 2024
    “…</p>Methods<p>SB102 (NCT05408572) focused on safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) endpoints. SON-1010 at 50-300 ng/kg or placebo administered subcutaneously on day 1 was studied at a ratio of 6:2, starting with two sentinels; participants were followed through day 29. …”
  16. 18096
  17. 18097
  18. 18098
  19. 18099
  20. 18100